Keenova Reports First Quarter 2026 Financial Results | MNK Stock NewsStockTitan·May 11 at 09:30 PMSEOVF-5.00%ITRM0.00%
Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking | MNK Stock NewsStockTitan·May 3 at 10:30 PMNBRVF0.00%ITRM0.00%
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week | MNK Stock NewsStockTitan·Apr 30 at 10:30 PMITRM0.00%NBRVF0.00%
06:30 ETKeenova Announces Unaudited Fourth Quarter 2025 Financial Resultsprnewswire·Mar 31 at 05:30 AMLABU+7.13%BBH-0.30%
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge | MNK Stock NewsStockTitan·Mar 26 at 10:30 PMRNVA0.00%SEOVF-5.00%
Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting | MNK Stock NewsStockTitan·Feb 23 at 10:30 PMSBIO+3.26%PBE-3.00%
Keenova's new manuscript on plantar fibromatosis treatment patterns in foot surgery journal highlights mostly conservative treatments for the rare condition, emphasizing need for long-term outcome research.Unusual Whales·Feb 16 at 06:33 AMARKG+4.69%IXJ-1.16%
07:30 ETKeenova Announces New Manuscript on Plantar Fibromatosis Treatment Patterns in Peer-Reviewed Journal of Foot and Ankle Surgeryprnewswire·Feb 16 at 06:32 AMITRM0.00%SBIO+3.26%
